ArticleMolecular cancer therapeutics2021

Targeting TfR1 with the ch128.1/IgG1 Antibody Inhibits EBV-driven Lymphomagenesis in Immunosuppressed Mice Bearing EBV

Laura E Martínez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.